Form D — Lapix Therapeutics Inc.
0001947620-25-000003 · filed Aug 5, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $2,200,000
- Minimum investment
- $1,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Lapix Therapeutics Inc.
- CIK
- 1947620
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 271 Cambridge St., 2nd Floor
Cambridge, Massachusetts 02141 - Phone
- 8582264717
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Anas Fathallah · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Jason Norris · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Henry McKinnell · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Francisco Leon · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Anthony Gibney · DirectorCambridge, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗